2024/09/27 17:32:29 | |
---|---|
Price | |
73.50 EUR | |
Difference | 2.08% (1.50) |
ISIN | US4364401012 |
Symbol | HOLX |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 16,647 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 72.00 EUR |
High | 73.50 EUR |
Low | 72.00 EUR |
Close (prev. day) | 72.00 EUR |
VWAP | 75.00 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/09/27 17:32:29 | |
---|---|
Price | |
73.50 EUR | |
Difference | 2.08% (1.50) |
ISIN | US4364401012 |
Symbol | HOLX |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 16,647 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 72.00 EUR |
High | 73.50 EUR |
Low | 72.00 EUR |
Close (prev. day) | 72.00 EUR |
VWAP | 75.00 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +2.86% | +8.70% | +9.72% |
Perf (abs.) | +2.00 | +5.76 | +6.38 |
Beta | 0.13 | 0.27 | 0.58 |
Volatility | 22.19 | 20.19 | 22.48 |
Ø price 5 days | Ø volume 5 days (pcs.) | 72.70 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 73.28 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 71.51 EUR (4) |
Ø price 250 days | Ø volume 250 days (pcs.) | 69.13 EUR (2) |
YTD High | date | 77.00 EUR (2024/07/31) |
YTD Low | date | 64.38 EUR (2024/01/09) |
52 Weeks High | date | 77.00 EUR (2024/07/31) |
52 Weeks Low | date | 60.90 EUR (2023/10/30) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/09/27 | 17:32 | 73.50 EUR | 0.00 | 5 |
Tradegate | 2024/09/26 | 22:26 | 72.00 EUR | 0.01 | 2 |
Stuttgart | 2024/09/27 | 08:03 | 71.50 EUR | 0.00 | 1 |
Nasdaq | 2024/09/27 | 21:04 | 80.77 USD | 31.37 | 12,569 |
Munich | 2024/09/27 | 17:26 | 73.00 EUR | 0.00 | 2 |
London Stock Exchange | 2024/08/28 | 15:49 | 80.29 USD | 0.01 | 1 |
Hanover | 2024/09/27 | 17:25 | 73.00 EUR | 0.00 | 2 |
Frankfurt | 2024/09/27 | 09:26 | 71.50 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/27 | 19:31 | 72.00 EUR | 0.00 | 5 |
Berlin | 2024/09/27 | 08:08 | 71.50 EUR | 0.00 | 1 |
HOLOGIC INC. |
- - |
250 Campus Drive - 01752 Marlborough |
Telefon: +1-508-263-2900 |
Fax: + |
E-mail: info@hologic.com |
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on womenšs health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA. |
Ludwig Hantson | Member of Board of Directors |
Amy McBride-Wendell | Member of Board of Directors |
Charles Dockendorff | Member of Board of Directors |
Christiana Stamoulis | Member of Board of Directors |
Nanaz Mohtashami | Member of Board of Directors |
Sally Crawford | Member of Board of Directors |
Scott Garrett | Member of Board of Directors |
Stacey Stewart | Member of Board of Directors |
Stephen P. MacMillan | Chairman of Managing Board |
Karleen Oberton | Member of Executive Committee |
Paul Malenchini | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer